Lösung für einen Vernebler clinical trials

Reduction of SystemiC Inflammation after ischemic stroke by intravenous DNase administration (ReSCInD)

This study looks at whether a drug called DNase can help reduce swelling and damage in the brain after a stroke. Researchers are testing if it lowers a chemical called IL-1β in the blood, which is linked to inflammation.